Literature DB >> 22116626

Pure red cell aplasia with follicular lymphoma showing regression and progression parallel to lymphoma.

Go Yamamoto, Hiroaki Maki, Motoshi Ichikawa, Mineo Kurokawa.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22116626     DOI: 10.1007/s12185-011-0969-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  6 in total

1.  Pure red cell aplasia associated with non-Hodgkin's lymphoma and hemolytic anemia.

Authors:  A Suzuki; T Takahashi; A Taniguchi; C Kotake; T Seo; T Toda; K Kobayashi; N Tsukamoto; M Fukumoto
Journal:  Jpn J Clin Oncol       Date:  1991-10       Impact factor: 3.019

2.  Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasia.

Authors:  F C Firkin; D Maher
Journal:  Eur J Haematol       Date:  1988-09       Impact factor: 2.997

3.  Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia.

Authors:  M Zecca; P De Stefano; B Nobili; F Locatelli
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

Review 4.  Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas.

Authors:  Alexander W Hauswirth; Cathrin Skrabs; Christian Schützinger; Alexander Gaiger; Klaus Lechner; Ulrich Jäger
Journal:  Leuk Lymphoma       Date:  2007-06

5.  Spectrum of pure red cell aplasia in adult population of north-west India.

Authors:  Pankaj Malhotra; G K Muralikrishna; Neelam Varma; Savita Kumari; Reena Das; Jasmina Ahluwalia; Sanjay Jain; Subhash Varma
Journal:  Hematology       Date:  2008-04       Impact factor: 2.269

6.  Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group.

Authors:  Makoto Hirokawa; Ken-ichi Sawada; Naohito Fujishima; Fumio Kawano; Akiro Kimura; Takashi Watanabe; Ayako Arai; Toshimitsu Matsui; Shinji Nakao; Akio Urabe; Mitsuhiro Omine; Keiya Ozawa
Journal:  Am J Hematol       Date:  2009-03       Impact factor: 10.047

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.